Agoracom Blog Home

Posts Tagged ‘bot’

« Older Entries
Newer Entries »

Datametrex $DM.ca Awarded Tender for COVID-19 Test Kits From Canadian Mining Company

Posted by AGORACOM-JC at 8:19 AM on Friday, June 5th, 2020
  • Awarded a tender for COVID-19 test kits from a Quebec based mining company; the Supply Arrangement
  • Under the SA, the mining company will order an initial 2,000 units of Health Canada authorized COVID-19 qPCR Detection Kits manufactured by 1drop Inc. with testing being conducted by Transpharm Canada Inc.
  • Datametrex anticipates that it will have little or no upfront costs associated with the sale of these test kits

TORONTO, June 05, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has been awarded a tender for COVID-19 test kits from a Quebec based mining company; the Supply Arrangement (the “SA”).

Under the SA, the mining company will order an initial 2,000 units of Health Canada authorized COVID-19 qPCR Detection Kits manufactured by 1drop Inc. with testing being conducted by Transpharm Canada Inc. (“TCI”). The Company has secured all testing kits from the manufacturer required to fulfill the order. All of the items will be shipped directly from manufacturer to the TCI lab. Datametrex anticipates that it will have little or no upfront costs associated with the sale of these test kits.

“By offering security technologies, Datametrex reaffirms its commitment to its customers, shareholders, families, and the Canadian public. We sincerely hope to aid in the reopening of businesses and social and cultural events in a safe and economic way,” said Marshall Gunter, CEO of Datametrex.

Infectious disease experts have indicated that without continuous testing there is a higher possibility of a second outbreak. According to Canada’s chief public health officer, Dr. Theresa Tam, reopening schools and businesses relies on testing and the ability of public health departments to trace the contacts of positive cases.

Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.

About Transpharm Canada Inc.

Transpharm Canada Inc. provides pharmaceutical education, technology, and research opportunities to students through its subsidiary, Toronto Institute of Pharmaceutical Technology, North America’s premier pharmaceutical training institute. The facility is also fully compliant Health Canada licensed Good Manufacturing Practice (“GMP”) manufacturing and testing facility and is a full-service clinical development business that provides clinical trial services to biotechnology companies.  Additional information on TIPT is available at www.tipt.com.

About 1drop Inc.

1drop Inc. aims to provide a solution to manage health with a drop of fluid. It has the key technologies for becoming a global leading company in the field of smart health care. 1copy™ COVID-19 qPCR Multi Kit can reduce the risk of asymptomatic and latent infection of COVID-19 by a single virus level limit of detection. Additional information on 1drop Inc. is available at www.1drop.co.kr.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Awarded Tender for COVID-19 Test Kits From Canadian Mining Company

Five Tell-Tale Signs Of A Fake News Story – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 5:42 PM on Thursday, June 4th, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company is working with US Government agencies on Covid19 and Coronavirus fake news and disinformation. The company also obtained the rights to import and sell COVID-19 test kits from South Korea – Click here for more info.

Five Tell-Tale Signs Of A Fake News Story

  • As you know, there has been a lot of talk about fake news stories lately, and tech companies, like Facebook and Google, have been looking for ways to incorporate fact-checking into their operations
  • These attempts to keep misinformation at bay will no doubt be helpful, but in the end, much of the responsibility lies with the readers themselves

By: Bernadette Coleman

The other day, I shared a news story I had received in my inbox with my husband. After reading him the email, he gave me a glance, slowly put the “loser” finger sign to his forehead in jest and simply said, “fake news.” Was it? At first glance, I didn’t think it was, so I looked again.

As you know, there has been a lot of talk about fake news stories lately, and tech companies, like Facebook and Google, have been looking for ways to incorporate fact-checking into their operations. These attempts to keep misinformation at bay will no doubt be helpful, but in the end, much of the responsibility lies with the readers themselves. I decided to not fall for fake news again.

It was at that moment of clarity that I really started looking. Now, if I encounter a news story that seems rather odd or hard to believe, I thoroughly vet that information as well as I can before passing it on to my husband and friends or discussing it with my colleagues at work. As I recently found out, falling for a fake news story can leave you feeling gullible, and passing on that false information could have far-reaching implications for the wider population. At least it will have your significant other looking at you oddly.

I figured the best defense against being suckered in by all the misinformation on the internet is to be well-read and well-informed on topics that interest me. The more I know about the world around me, the easier it will be for me to spot the tell-tale signs of a fake news story.

So here are some signs that the story you and I are reading may be less than truthful.

1. Unusual Or Unknown Web Addresses

Whether you are browsing through your Facebook feed, checking out your favorite news aggregator or reviewing the results of your latest search query, pay careful attention to the source of the story. You should be checking out the URL associated with the news story.

An unusual or unknown web address is a big red flag and a sign that you are dealing with a fake news source. Watch out for URLs that look similar to real news sources. Sites like msnbc.com.com or nytimes.biz may appear legitimate at first glance, but the unusual web address is a dead giveaway.

2. A Lack Of Corroboration

If a major political party candidate has been indicted on the eve of an election, you would expect to find those news headlines everywhere. If all you can find is a single headline in your Facebook newsfeed, you can be fairly certain the story is fake.

Whenever you spot an unusual story or piece of late-breaking news, you should first look for corroboration elsewhere. If the story is legitimate, it will show up on mainstream news sites that you recognize. If the story is a fake, it will probably be confined to more questionable sites, and that lack of corroboration should lead you to do further research.

3. An Old Date On A ‘Breaking’ News Story

One common trick of fake news publishers is presenting an outdated or previously debunked story as breaking news. When users click on a banner headline in search of breaking news, they often find an old story presented as if it were brand new.

Get into the habit of checking the dates on stories you read and links you click. If the date is an old one, you can be sure you are not dealing with new information.

You can go further and check to see if the story has been debunked since its original publication. Myth-busting sites like Snopes.com can be great for this kind of thing.

4. An Obvious Slant Or Bias By The Authors

One of the hallmarks of professional journalists is their independence, so an obvious slant or bias by the author can be a red flag. Even jaded readers who feel the mainstream media carries an inherent bias should be suspicious of stories that appear to support one side over the other in an obvious way, so always ask yourself what the writer has to gain.

A certain degree of bias is to be expected in an opinion piece or editorial. However, if the story is presented as straight reporting or journalism, an obvious slant might be an indication that the entire piece is fake.

5. A Sensational Headline

News writers work hard to get the attention of their readers. That is what headline writing is all about. That same dynamic holds true on the internet, where the competition for eyeballs is even more intense. Even so, if a headline seems like clickbait, it probably is.

A sensational headline is one of the tell-tale signs of a fake news story, and you should proceed with caution when you see one. If the headline would be more at home on a supermarket tabloid than in a real newspaper, the associated story could be fake.

Despite the efforts of Facebook, Google and other online giants, fake news stories are unlikely to disappear any time soon. With so many sites competing for viewers and so much money to be made, fake news publishers will probably be around for quite some time. The best way to protect yourself is to be an educated reader. The more you know, the easier it will be to tell the fake news stories from their legitimate counterparts.

I believe we need to cultivate an awareness of what’s fake and what’s not fake on the internet. Helping people understand that when they share fake news, they are littering our space is a must. We can only do this if we do this together!

Source: https://www.forbes.com/sites/forbesagencycouncil/2020/06/04/five-tell-tale-signs-of-a-fake-news-story/#619fd7ad7d79

Tags: , , , , , ,
Posted in Datametrex AI Limited | Comments Off on Five Tell-Tale Signs Of A Fake News Story – SPONSOR: Datametrex AI Limited $DM.ca

Datametrex $DM.ca Reports Government Clearance To Fulfill Its First #COVID19 Test Kit Order

Posted by AGORACOM-JC at 2:17 PM on Wednesday, June 3rd, 2020
  • Announced that its purchaser has received Government clearance to fulfill the purchase order for COVID-19 test kits for its client, a mining company operational in Mali, West Africa
  • Under the terms of the PO, Datametrex will sell to the purchaser an initial 10,000 units of the iONEBIO Inc. iLAMP Novel-CoV19 Detection Kit; 10,000 3 mL Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes with Plastic Red Capture Caps, and 1 Real-Time PCR Detection System machine to analyze the samples
  • The total gross sales amount is approximately $500,000 CDN, excluding shipping

TORONTO, June 03, 2020 – Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that its purchaser has received Government clearance to fulfill the purchase order (the “PO”) for COVID-19 test kits for its client, a mining company operational in Mali, West Africa.

Under the terms of the PO, Datametrex will sell to the purchaser an initial 10,000 units of the iONEBIO Inc. iLAMP Novel-CoV19 Detection Kit; 10,000 3 mL Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes with Plastic Red Capture Caps, and 1 Real-Time PCR Detection System machine to analyze the samples. The iONEBIO test kits provide results within approximately 15 to 20 minutes with 99.9% accuracy. Each kit contains 288 individual tests, all of which can be completed in one hour.

The total gross sales amount is approximately $500,000 CDN, excluding shipping. The Company has secured all testing kits, swabs, tubes and the PCR machine from the manufacturer required to fulfill the order. Datametrex anticipates that it will have little or no upfront costs associated with the sale of these test kits.

With the Government clearance, the Company is in process of organizing shipping. All of the items will be shipped directly from manufacturers to the purchaser at their operating site in West Africa. Security clearance backlogs continue to streamline as Governments align with the World Health Organization’s remarks on the importance of testing. Governments have urged mining companies to implement testing and screening their workforce to properly fight the virus in order to avoid further closures.

“The opportunity to use advanced COVID-19 testing kits from our partners in Korea to support the diagnostic potential for populations provides an exciting opportunity for countries during this pandemic and the African continent,” says Marshall Gunter, CEO of the Company. “Datametrex is honored to be assisting in the health and welfare of mine employees and local contractors.”

According to Africa Centres for Disease Control and Prevention (the “Africa CDC”), there are over 150,000 cases of COVID-19 throughout Africa and with this, Researchers at the African Center of Excellence for Genomics of Infectious Diseases (the “ACEGID”) and other research and public health partners, have announced to implement a Sentinel Project (the “Sentinel”) serveilance protocol for an early warning system in Africa. The Sentinel is the first of eight new projects selected, and it has three pillars: (1) detect, (2) connect and (3) empower. And in the third pillar, the project will empower public health experts by training thousands of healthcare professionals to use the Sentinel tools and deploy the diagnostic technologies for population-level COVID-19 testing, building on previous experiences of ACEGID and the Broad Institute in training over 900 individuals from around the world.

Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Reports Government Clearance To Fulfill Its First #COVID19 Test Kit Order

#AI tools could improve fake news detection by analyzing users’ interactions and comments – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 5:12 PM on Tuesday, June 2nd, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company is working with US Government agencies on Covid19 and Coronavirus fake news and disinformation. The company also obtained the rights to import and sell COVID-19 test kits from South Korea – Click here for more info.

AI tools could improve fake news detection by analyzing users’ interactions and comments

  • According to the Pew Research Center, approximately 68% of U.S. adults got their news from social media in 2018 — which is worrisome, considering misinformation about the pandemic, for instance, continues to go viral
  • Companies from Facebook and Twitter to Google are pursuing automated detection solutions, but fake news remains a moving target, owing to its topical and stylistic diversity

By: Kyle Wiggers

In a paper published on the preprint server Arxiv.org, researchers affiliated with Microsoft and Arizona State University propose an approach to detecting fake news that leverages a technique called weak social supervision. They say that by enabling the training of fake news-detecting AI even in scenarios where labeled examples aren’t available, weak social supervision opens the door to exploring how aspects of user interactions indicate that news might be misleading.

According to the Pew Research Center, approximately 68% of U.S. adults got their news from social media in 2018 — which is worrisome, considering misinformation about the pandemic, for instance, continues to go viral. Companies from Facebook and Twitter to Google are pursuing automated detection solutions, but fake news remains a moving target, owing to its topical and stylistic diversity.

Building on a study published in April, the coauthors of this latest work suggest that weak supervision — where noisy or imprecise sources provide data labeling signals — could improve fake news detection accuracy without requiring fine-tuning. To this end, they built a framework dubbed Tri-relationship for Fake News (TiFN) that models social media users and their connections as an “interaction network” to detect fake news.

Interaction networks describe the relationships between entities like publishers, news stories, and users. Given an interaction network, TiFN aims to embed different types of entities, based on the observation that people tend to interact with like-minded friends. In making its predictions, the framework also accounts for the fact that connected users are more likely to share similar interests in news pieces, that publishers with a high degree of political bias are more likely to publish fake news, and that users with low credibility are more likely to spread fake news.VB Transform 2020 Online – July 15-17. Join leading AI executives: Register for the free livestream.

To test whether TiFN’s weak social supervision could help to detect fake news effectively, the team validated it against a Politifact data set containing 120 true news pieces and 120 verifiably fake pieces shared among 23,865 users. Versus baseline detectors that consider only news content and some social interactions, the researchers report that TiFN achieved between 75% to 87% accuracy, even with a limited amount of weak social supervision (within 12 hours after the news was published).

In another experiment — involving a separate custom framework called Defend — the researchers sought to use news sentences and user comments explaining why a piece of news is fake as a weak supervision signal. Tested on a second Politifact data set consisting of 145 true news and 270 fake news pieces with 89,999 comments from 68,523 users on Twitter, they say Defend achieved 90% accuracy.

“[W]ith the help of weak social supervision from publisher-bias and user-credibility, the detection performance is better than those without utilizing weak social supervision. We [also] observe that when we eliminate [the] news content component, user comment component, or the co-attention for news contents and user comments, the performances are reduced. [This] indicates capturing the semantic relations between the weak social supervision from user comments and news contents is important,” wrote the researchers. “[W]e can see [that] within a certain range more weak social supervision leads to a larger performance increase, which shows the benefit of using weak social supervision.”

Source: https://venturebeat.com/2020/06/01/ai-tools-could-improve-fake-news-detection-by-analyzing-users-interactions-and-comments/

Tags: , , , ,
Posted in Datametrex AI Limited | Comments Off on #AI tools could improve fake news detection by analyzing users’ interactions and comments – SPONSOR: Datametrex AI Limited $DM.ca

Datametrex $DM.ca Reports First Quarter Results

Posted by AGORACOM-JC at 8:42 AM on Wednesday, May 27th, 2020

Highlights for Q1 2020

  • The Company completed work for Democracy Labs on #disinformation in social media regarding #covid19 and #coronavirus and secured a relationship with Carnegie Mellon University IDeaS. These projects assisted in getting Nexalogy in front of the Government Agencies for the opportunity in the United States.
  • The Company continued the second phase of a multi-phase R&D program through the Department of National Defence’s Innovation for Defence Excellence and Security IDEaS program.  
  • The Company was chosen as preferred vendor partner by LOTTE Data Communication.

TORONTO, May 27, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce its financial results for Q1, ended March 31, 2020. 

Although certain projects and various sales negotiations have been postponed due to COVID-19 outbreaks, the Company was able to expand its businesses, and recorded increase in revenue for Q1 2020 by 62%, $809,402 compared to $498,565 in the previous year. Operating costs were reduced by 31% to $1,162,723 compared to $1,692,958 in the previous year. The net results  improved significantly with a decrease by 25%, ($721,761) compared to ($904,792) in the previous year. The Adjusted EBITDA also had a significant improvement with a decrease by 177%, ($257,303) compared to ($712,256). 

“In Q1 2020, we achieved multiple key milestones and made significant strides in strengthening our AI platform and offering, reducing operating costs, increasing sales, and focusing on our core business. This resulted in a substantial improvement to the bottom line,” says Marshall Gunter, CEO of the Company.

Highlights for Q1 2020

  • The Company completed work for Democracy Labs on #disinformation in social media regarding #covid19 and #coronavirus and secured a relationship with Carnegie Mellon University IDeaS. These projects assisted in getting Nexalogy in front of the Government Agencies for the opportunity in the United States.
  • The Company continued the second phase of a multi-phase R&D program through the Department of National Defence’s Innovation for Defence Excellence and Security IDEaS program.  
  • The Company was chosen as preferred vendor partner by LOTTE Data Communication.

Financial Highlights

The following table summarizes revenue, net loss and EBITDA* and Adjusted EBITDA* for the three months ended March 31, 2020 and 2019.

 For the three months ended 
 March 31, 2020 March 31, 2019 %
 $ $  
REVENUE  809,402   498,565 62%
NET LOSS  (721,761)  (904,792)25%
EBITDA  (528,303)  (723,529)37%
EBITDA per share  (0.002)  (0.003)68%
Adjusted EBTDA  (257,303)  (712,256)177%
Adjusted EBITDA per share  (0.001)  (0.003)34%

* Note: EBITDA (non-IFRS measures) is calculated as Net Loss ($721,761) adjusted for 1. Income taxes of ($16,207), 2. Depreciation and amortization of $194,899, and 3. Interest and accretion of $14,766. Adjusted EBITDA (non-IFRS measures) is calculated as EBITFA adjusted for share based compensation of 271,000.

Non-IFRS financial measures do not have standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Specific items may only be relevant in certain periods. For reconciliation of non-IFRS financial measures please refer to the Company’s Management Discussion and Analysis for the three months ended March 31, 2020.

The financial statements, notes to the financial statements and Management’s Discussion and Analysis for the three months ended March 31, 2020 are available on the Company’s profile at SEDAR at www.sedar.com.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Jeff Stevens- Advisor
Phone: (647) 400-8494
Email: [email protected]

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , ,
Posted in Datametrex AI Limited | Comments Off on Datametrex $DM.ca Reports First Quarter Results

INTERVIEW: Datametrex $DM.ca Sells 10,000 COVID-19 Test Kits In $500,000 Deal With Global Mining Company

Posted by AGORACOM-JC at 9:16 AM on Thursday, May 21st, 2020

When US Government Agencies call you in the middle of the greatest health and economic crisis in 100 years to help them detect social media disinformation about COVID-19, it is safe to assume your Artificial Intelligence capabilities to detect fake news, disinformation campaigns and their impact is amongst the most respected in the world.

Then, when the Canadian government calls on you to help with the import and sale of COVID-19 test kits from South Korea, it is also safe to assume your trust and security clearances are at the highest levels possible.

But the real credibility payoff comes when a global mining giant, with 4,000 employees across the world, knocks on your door to buy 10,000 kits for the purposes of protecting both their employees and their families in order to get operations re-started.

You would probably also assume such a company to be a tech giant or a Silicon Valley funded startup. But Datametrex AI (DM: TSXV) is neither. Rather, it is a great Canadian small cap technology company who is giving small cap investors an opportunity to participate in the emerging world of Artificial Intelligence, as well as, the brand new world of COVID-19 testing.

When a small cap Artificial Intelligence company is successfully deploying its technology with military and conglomerates, as well as, being called upon by the Canadian federal government and global conglomerates to ask for help with the greatest pandemic in 100 years, smart small cap investors are compelled to take a closer look.

That look can begin with our latest interview of Datametrex CEO, Marshall Gunter, who discusses how the Company was able to secure its first order of 10,000 COVID-19 test kits for $500,000.

Watch this interview or listen by Podcast on Apple, Google, Spotify or your favourite podcaster.

Tags: , , , ,
Posted in AGORACOM Via Satellite, Datametrex AI Limited, Featured | Comments Off on INTERVIEW: Datametrex $DM.ca Sells 10,000 COVID-19 Test Kits In $500,000 Deal With Global Mining Company

Datametrex $DM.ca Enters Strategic Agreement to Help Provide for Processing of COVID-19 Tests for Canadian Companies

Posted by AGORACOM-JC at 9:09 AM on Thursday, May 21st, 2020
  • Signed a Strategic Partnership and Development Agreement with Transpharm Canada Inc.
  • Under the term of the Agreement TCI will work with Datametrex on scoping out services and providing access to its 25,000 sq. ft state-of-the-art testing facility located in Toronto, ON, to provide support and testing services for COVID-19 testing kits that Datametrex has in its portfolio
  • Datametrex will be providing the COVID-19 test kits. TCI will be providing all other services including but not limited to the collection of specimens, transport of specimens, and processing test results.

TORONTO, May 21, 2020 – Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that is has signed a Strategic Partnership and Development Agreement (the “Agreement”) with Transpharm Canada Inc. (“TCI”).

Under the term of the Agreement TCI will work with Datametrex on scoping out services and providing access to its 25,000 sq. ft state-of-the-art testing facility located in Toronto, ON, to provide support and testing services for COVID-19 testing kits that Datametrex has in its portfolio. Datametrex will be providing the COVID-19 test kits. TCI will be providing all other services including but not limited to the collection of specimens, transport of specimens, and processing test results.

TCI will design, engineer, and develop a fully integrated suite of testing systems that will include in the field and lab testing protocols using TCI’s fully compliant Health Canada licensed Good Manufacturing Practice (“GMP”) manufacturing and testing facility. TCI lab has a current capacity to process 2,304 nucleic acid COVID-19 real-time detection kits (the “Kits”) every 24 hrs using CFX96 real-time PCR detection system machines and is scalable to over 10,000 test kits every 24 hrs.

Transpharm will develop a Point of Care Diagnostic Kit System (the “TCI System”) with clear protocols of specimen collection, specimen handling, and specimen container labeling including the patient’s full name, date of collection, and one other unique identifier such as date of birth or government issued health card number. Transpharm will also develop a procedure focused around delivery related to specimen transport media tube protocols including to ensure cap on tube is tightly sealed, shipped at 2-8°C, 26-46°F to the TCI laboratory testing facility.

Datametrex is committed to helping Canada and Canadians find a safe and secure way to get people out of lockdown and back to work. The Company first identified the need for high quality test kits back in April, since then, it has established relationships with four South Korean manufacturers of nucleic acid test kits. The Company quickly identified that both public and private corporations are not fully equipped to administer and process the test kits on their own. As a result, the Company quickly sourced a qualified lab testing company to partner with that will provide customers with a turnkey solution to administer tests efficiently, safely, and accurately. The Company believes testing is going to be key to re-opening the economy in a safe fashion, and also believes in providing Canadians with the best solution. 

“By participating in this project, Datametrex reaffirms its commitment to helping it customers, shareholders, families, and the Canadian public. This project hopes to aid in the reopening of businesses, travel, places of worship, community spaces, and social and cultural events in a safe and economic way,” said Marshall Gunter, CEO of Datametrex.

Dr. Alexander MacGregor, founder and President of TCI, stated, “Transpharm is pleased to join in the COVID-19 fight with Datametrex and provide a world class testing facility for this endeavour. This world pandemic poses an unprecedented threat to the way that most people live their daily lives. There are several obvious steps we can take to ensure that no one must choose between their health and leaving their homes, and that begins with testing. Transpharm has the people, the equipment, and world class lab space to meet the enormous demand coming and to get the job done.”

About Transpharm Canada Inc

Transpharm Canada Inc. provides pharmaceutical education, technology, and research opportunities to students through its subsidiary, Toronto Institute of Pharmaceutical Technology, North America’s premier pharmaceutical training institute. The facility is also fully compliant Health Canada licensed Good Manufacturing Practice (“GMP”) manufacturing and testing facility and is a full-service clinical development business that provides clinical trial services to biotechnology companies.  Additional information on TIPT is available at www.tipt.com

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations, and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , ,
Posted in Datametrex AI Limited | Comments Off on Datametrex $DM.ca Enters Strategic Agreement to Help Provide for Processing of COVID-19 Tests for Canadian Companies

Datametrex $DM.ca Adds Pharmacologist Alex MacGregor to the Medical Advisory Board

Posted by AGORACOM-JC at 10:04 AM on Tuesday, May 19th, 2020
  • President and Dean of the Toronto Institute of Pharmaceutical Technology and Clinical Pharmacologist, Dr. Alexander MacGregor, Ph.D., a, has consented to join the Company’s Medical Advisory Board.
  • Company is also in discussion with Transpharm Canada Inc. the parent company of Toronto Institute of Pharmaceutical Technology to provide lab testing services using there fully compliant Health Canada licensed Good Manufacturing Practice manufacturing and testing facility located in Toronto, ON, Canada

TORONTO, May 19, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that President and Dean of the Toronto Institute of Pharmaceutical Technology (“TIPT”) and Clinical Pharmacologist, Dr. Alexander MacGregor, Ph.D., a, has consented to join the Company’s Medical Advisory Board.

The Company is also in discussion with Transpharm Canada Inc. (“TCI”), the parent company of Toronto Institute of Pharmaceutical Technology to provide lab testing services using their fully compliant Health Canada licensed Good Manufacturing Practice (“GMP”) manufacturing and testing facility located in Toronto, ON, Canada. Having a mass testing partner will be a key growth driver for the Company and will be working to solidify an agreement on this prospective joint project.

Datametrex is extremely pleased to have an medical patent holder and pharmacologist with the experience and abilities of Dr. MacGregor join its Medical Advisory Board,” said Marshall Gunter, CEO of Datametrex. “Alexander will be an excellent source of advice as the Company advances a key part of covid-19 with lab capacity and his and his teams pharmacology expertise. We welcome Dr. MacGregor and look forward to his valued contribution as the newest member of our team.”

Dr. Alexander MacGregor stated, “I am very pleased to join the Company’s medical advisory board. With this unprecedented pandemic terribly affecting people worldwide and has temporarily changed the way the world operates, I am pleased to be assisting Datametrex with my teams expertise in lab testing on the front lines and assisting developing a plan to meet the enormous demand coming in COVID-19 testing and working on lowering the curve during this outbreak.”

About Dr. Alexander MacGregor

A leader in the fields of pharmaceutical technology, research, and training, Dr. MacGregor has served as the President and Dean of Faculty of the Toronto Institute of Pharmaceutical Technology (TIPT®) since 1992.

The holder of several scientific patents, Dr. MacGregor currently oversees clinical testing trials of several drugs in the areas of cholesterol lowering, diabetes, anti-infective, post-operative pain, epilepsy, and congestive heart failure.

Dr. MacGregor obtained his Ph.D. in clinical pharmacology from the University of London Postgraduate Medical School after earning B.Sc. (Honors) in Medical Biochemistry from the Cardif University in Wales. In 1997, Dr. MacGregor completed a Master-Class Certification Program in Pharmaceutical Technology from the European Continuing Education College at the University of Liverpool.

In 1990, Dr. MacGregor moved to Canada to assume the role of managing director of Transpharm International UK Ltd., a scientific enterprise specializing in clinical testing and pharmaceutical drug licensing. Throughout the decade, Dr. MacGregor functioned as a consultant to major pharmaceutical industries in Europe, Asia, and North America.

Dr. MacGregor currently divides his time between TIPT, one of North America’s leading postgraduate pharmaceutical and research organizations, and ORx Pharmaceutical Corporation, where he serves as chairman and Chief Scientific Officer. In the latter capacity, Dr. MacGregor designs and develops clinical delivery methods of therapeutic compounds.

At TIPT, Dr. MacGregor runs a highly regarded training program in pharmaceutical sciences and technology. More than 7,500 successful TIPT graduates operate in all areas of the pharmaceutical industry including quality control analysis, regulatory affairs administration, clinical quality control, and clinical data review.

An active humanitarian within the African-Canadian community, Dr. MacGregor supports such organizations as the Canadian Association of Black Lawyers (CABL) and the Association of Black Law Enforcers (ABLE). Dr. MacGregor also donates generously to charities such as the United Way and the Nelson Mandela Children’s fund.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Adds Pharmacologist Alex MacGregor to the Medical Advisory Board

Datametrex Announces Sale of COVID-19 Test Kit to Canadian Mining Company

Posted by AGORACOM-JC at 10:27 AM on Friday, May 15th, 2020
  • Received a purchase order for COVID-19 test kits from a Canadian based mining company with over 4,000 employees in multiple jurisdictions outside of Canada
  • Under the terms of the PO, Datametrex will sell to the purchaser an initial 10,000 units of COVID-19 Detection Kits, comprising of 10,000 3 mL Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes with Plastic Red Capture Caps, and 1 Real-Time PCR Detection System machine to analyze the samples
  • Total gross sales amount is approximately $500,000 CDN, excluding shipping

TORONTO, May 15, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce it has received a purchase order for (the “PO”) COVID-19 test kits from a Canadian based mining company with over 4,000 employees in multiple jurisdictions outside of Canada.

Under the terms of the PO, Datametrex will sell to the purchaser an initial 10,000 units of COVID-19 Detection Kits, comprising of 10,000 3 mL Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes with Plastic Red Capture Caps, and 1 Real-Time PCR Detection System machine to analyze the samples. The total gross sales amount is approximately $500,000 CDN, excluding shipping. Datametrex anticipates that it will have little or no upfront costs associated with the sale of these test kits. The Company has secured all testing kits, swabs, tubes and the PCR machine from the manufacturer required to fulfill the order. All of the items will be shipped directly from manufacturers to the purchaser at their operating site in Africa.

“Datametrex is honoured to be assisting this Canadian company to protect and safeguard the health and welfare of their employees, local contractors, and the local population. We are proud to be able to help Canadians and companies to reopen businesses around the world and to help people return to work safely. We sincerely wish them and all Canadian companies the best during this pandemic,” says Marshall Gunter, CEO of the Company.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex Announces Sale of COVID-19 Test Kit to Canadian Mining Company

How #Facebook is using #AI to combat #COVID19 misinformation and detect ‘hateful memes’ – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 5:46 PM on Tuesday, May 12th, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company is working with US Government agencies on Covid19 and Coronavirus fake news and disinformation. The company also obtained the rights to import and sell COVID-19 test kits from South Korea – Click here for more info.

How Facebook is using AI to combat COVID-19 misinformation and detect ‘hateful memes’

By Nick Statt

Facebook on Monday released a new report detailing how it uses a combination of artificial intelligence and human fact-checkers and moderators to enforce its community standards. The report — called the Community Standards Enforcement Report, which usually encompasses data and findings from the prior three to six months — has a large focus on AI this time around.

That’s because Facebook is relying more on the technology to help moderate its platform during the COVID-19 pandemic, which is preventing the company from using its usual third-party moderator firms because those firms’ employees are not allowed to access sensitive Facebook data from home computers.

That said, Facebook says the data it’s compiled so far doesn’t contain any larger trends in its enforcement or in offending behavior on its platform because the pandemic hit so late in its reporting period. “This report includes data only through March 2020 so it does not reflect the full impact of the changes we made during the pandemic,” writes Guy Rosen, the company’s vice president of integrity, in a blog post. “We anticipate we’ll see the impact of those changes in our next report, and possibly beyond, and we will be transparent about them.’

Given the state of the world, Facebook’s report does contain new information about how the company is specifically combating coronavirus-related misinformation and other forms of platform abuse, like price gouging on Facebook Marketplace, using its AI tools. Facebook put warning labels on 50 million coronavirus-related posts last month

“During the month of April, we put warning labels on about 50 million posts related to COVID-19 on Facebook, based on around 7,500 articles by our independent fact-checking partners,” the company said in a separate blog post, penned by a group of its research scientists and software engineers, about its ongoing COVID-19 misinformation efforts published today. “Since March 1st, we’ve removed more than 2.5 million pieces of content for the sale of masks, hand sanitizers, surface disinfecting wipes and COVID-19 test kits. But these are difficult challenges, and our tools are far from perfect. Furthermore, the adversarial nature of these challenges means the work will never be done.”

Facebook says its labels are working: 95 percent of the time, someone who is warned that a piece of content contains misinformation will decide not to view it anyway. But producing those labels across its enormous platform is proving to be a challenge. For one, Facebook is discovering that a fair amount of misinformation as well as hate speech is now showing up in images and videos, not just text or article links.

“We have found that a substantial percentage of hate speech on Facebook globally occurs in photos or videos,” the company says in a separate hate speech-specific blog post about its recent moderation findings and research. “As with other content, hate speech also can be multimodal: A meme might use text and image together to attack a particular group of people, for example.”

This is a tougher challenge for AI to tackle, the company admits. Not only do AI-trained models have a harder time parsing a meme image or a video due to complexities like wordplay and language differences, but that software must also then be trained to find duplicates or only marginally modified versions of that content as it spreads across Facebook. But this is precisely what Facebook says it’s achieved with what it calls SimSearchNet, a multiyear effort across many divisions within the company to train an AI model how to recognize both copies of the original image and those that are near-duplicates and have perhaps one word in the line of text changed. “We have found that a substantial percentage of hate speech on Facebook globally occurs in photos or videos.”

“Once independent fact-checkers have determined that an image contains misleading or false claims about coronavirus, SimSearchNet, as part of our end-to-end image indexing and matching system, is able to recognize near-duplicate matches so we can apply warning labels,” the company says. “This system runs on every image uploaded to Instagram and Facebook and checks against task-specific human-curated databases. This accounts for billions of images being checked per day, including against databases set up to detect COVID-19 misinformation.”

Facebook uses the example of a misleading image modeled after a broadcast news graphic with a line of overlaid text reading, “COVID-19 is found in toilet paper.” The image is from a known peddler of fake news called Now8News, and the graphic has since been debunked by Snopes and other fact-checking organizations. But Facebook says it had to train its AI to differentiate between the original image and a modified one that says, “COVID-19 isn’t found in toilet paper.”

The goal is to help reduce the spread of duplicate images while also not inadvertently labeling genuine posts or those that don’t meet the bar for misinformation. This is a big problem on Facebook where many politically motivated pages and organizations or those that simply feed off partisan outrage will take photographs, screenshots, and other images and alter them to change their meaning. An AI model that knows the difference and can label one as misinformation and the other as genuine is a meaningful step forward, especially when it can then do the same to any duplicate or near-duplicate content in the future without roping in non-offending images in the process.

Source: https://www.theverge.com/2020/5/12/21254960/facebook-ai-moderation-covid-19-coronavirus-hateful-memes-hate-speech

Tags: , , , , ,
Posted in Datametrex AI Limited | Comments Off on How #Facebook is using #AI to combat #COVID19 misinformation and detect ‘hateful memes’ – SPONSOR: Datametrex AI Limited $DM.ca

« Older Entries
Newer Entries »